Eric Michael David | Chief Strategy Officer and Executive Vice President of Preclinical Development
Organovo

Appearances:

Day Two @ 11:40

Tissue-based cell therapy: a new route for precision med manufacturing

• Delivering functional, architectural tissue to replace or augment organ function
• Permitting delivery of gene therapy / iPSC / CART modified cells to solid organ targets
• Providing a highly reproducible, automated way to enable tissue engraftment and vascularization into target organs